(This March 2 story has been corrected to say that only one unit of BGI Genomics was added to the list and the Commerce department added a total of three BGI Group units, in paragraphs 1 and 2) (Reute[...]
Read more
Health
French insurer AXA outlines bond exposure to SVB and US regional banks
PARIS (Reuters) – French insurer AXA has a relatively small corporate bond exposure to Silicon Valley Bank, group Deputy CEO Frederic de Courtois told a Morgan Stanley investor conference this w[...]
Read more
Explainer-What is Microsoft-backed OpenAI’s GPT-4 model?
(Reuters) – Microsoft Corp-backed startup OpenAI began the rollout of GPT-4, a powerful artificial intelligence model that succeeds the technology behind the wildly popular ChatGPT. GPT-4 is[...]
Read more
Novo Nordisk to slash US insulin prices, following move by Eli Lilly
By Patrick Wingrove and Bhanvi Satija (Reuters) – Novo Nordisk said on Tuesday it would cut U.S. list prices for several insulin products by up to 75% next year, joining rival Eli Lilly and Co a[...]
Read more
US sues Rite Aid for missing opioid red flags
By Jonathan Stempel WASHINGTON (Reuters) – The U.S. government on Monday sued Rite Aid Corp, accusing the pharmacy chain of missing “red flags” as it illegally filled hundreds of tho[...]
Read more
Generali provides dividend cheer, no exposure to SVB
By Gianluca Semeraro MILAN (Reuters) – Italy’s Assicurazioni Generali surprised investors on Tuesday by hiking the dividend payout on its 2022 results after posting its best operating prof[...]
Read more
Amgen is sued for concealing $10.7 billion tax bill from investors
By Jonathan Stempel (Reuters) – Amgen Inc has been sued in a proposed class action accusing the drugmaker of waiting too long to tell investors it might owe the Internal Revenue Service $10.7 bi[...]
Read more
Factbox-Which companies are affected by SVB collapse?
(Reuters) – Startup-focused lender SVB Financial Group last week became the largest bank to fail since the 2008 financial crisis, sending shockwaves through the global financial system and promp[...]
Read more
SVB fall casts shadow on early-stage U.S. biotech
By Patrick Wingrove (Reuters) – The collapse of Silicon Valley Bank will leave early-stage biotechnology companies with a funding void, investors and analysts said on Monday, but larger, publicl[...]
Read more